Sign In
Buy CCXI
$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
ChemoCentryx Reports Second Quarter 2020 Financial Results and Recent Highlights
08:05pm, Monday, 10'th Aug 2020
\-- U.S. New Drug Application (NDA) submitted for avacopan in ANCA-associated vasculitis --\-- Balance sheet bolstered with $325.7 million in net proceeds from June follow-on offering; total cash, ca
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
12:00am, Sunday, 09'th Aug 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
Advisor Group Holdings Inc. Makes New Investment in ChemoCentryx Inc (NASDAQ:CCXI)
06:34am, Wednesday, 05'th Aug 2020
Advisor Group Holdings Inc. purchased a new position in ChemoCentryx Inc (NASDAQ:CCXI) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commi
Bio-Techne Corp (TECH) Q4 2020 Earnings Call Transcript | The Motley Fool
07:31pm, Tuesday, 04'th Aug 2020
TECH earnings call for the period ending June 30, 2020.
ChemoCentryx to Present at Two Upcoming Investor Conferences
12:30pm, Tuesday, 04'th Aug 2020
MOUNTAIN VIEW, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two up
ChemoCentryx to Hold Second Quarter 2020 Financial Results Conference Call on Monday, August 10, 2020
12:30pm, Monday, 03'rd Aug 2020
MOUNTAIN VIEW, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's second quarter 2020 financial results will be released after market clos
Earnings Preview: ChemoCentryx (CCXI) Q2 Earnings Expected to Decline
04:31pm, Monday, 27'th Jul 2020
ChemoCentryx (CCXI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How Much is ChemoCentryx's (NASDAQ:CCXI) CEO Getting Paid?
10:37am, Tuesday, 21'st Jul 2020
This article will reflect on the compensation paid to Thomas Schall who has served as CEO of ChemoCentryx, Inc...
Insiders Roundup: Mastercard, ChemoCentryx
03:02pm, Friday, 17'th Jul 2020
Largest insider trades of the week Continue reading...
Did Hedge Funds Make The Right Call On ChemoCentryx Inc (CCXI) ?
02:43pm, Monday, 13'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filin
Exane Derivatives Trims Stock Position in ChemoCentryx Inc (NASDAQ:CCXI)
06:08am, Monday, 13'th Jul 2020
Exane Derivatives decreased its holdings in ChemoCentryx Inc (NASDAQ:CCXI) by 24.3% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange C
Insiders Roundup: Mastercard, Eli Lilly
03:11pm, Friday, 10'th Jul 2020
Largest insider trades of the week Continue reading...
ChemoCentryx Submits New Drug Application to the U.S. FDA for Avacopan in ANCA-Associated Vasculitis
12:30pm, Thursday, 09'th Jul 2020
MOUNTAIN VIEW, Calif., July 09, 2020 -- ChemoCentryx, Inc., (NASDAQ: CCXI) today confirmed that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug.
3 “Perfect 10” Healthcare Stocks That Have Plenty Of Growth On Tap
12:00am, Thursday, 09'th Jul 2020
Stocks Analysis by Investing Insights covering: ChemoCentryx Inc, United Therapeutics Corporation, Axsome Therapeutics Inc. Read Investing Insights 's latest article on Investing.com
3 “Perfect 10” Healthcare Stocks That Have Plenty of Growth on Tap
03:14pm, Tuesday, 07'th Jul 2020
Disconnected. This seems to be the best way to describe the current economic environment. Amid high levels of unemployment and tanking earnings, stocks aren’t just hanging in there, they’re chargi
